| Rosalinda L Raya, DDS | |
|
106 Pollasky, Suite B, Clouis, CA 93612 | |
| (559) 298-2231 | |
| (559) 298-3148 |
| Full Name | Rosalinda L Raya |
|---|---|
| Gender | Female |
| Speciality | Dentist - General Practice |
| Location | 106 Pollasky, Clouis, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235295205 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 25442 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Rosalinda L Raya, DDS 106 Pollasky, Suite B, Clouis, CA 93612 Ph: (559) 298-2231 | Rosalinda L Raya, DDS 106 Pollasky, Suite B, Clouis, CA 93612 Ph: (559) 298-2231 |
News Archive
eCareSoft, Inc., a leading provider of healthcare IT solutions for the small hospital market, today announced the launch of its national "eCS Preferred Partner" program. The channel partner program provides support and training to best-of-class providers seeking an affordable EHR solution to expand their network of small and rural hospitals.
"The Global Fund to Fight AIDS, Tuberculosis and Malaria today welcomed the payment by Japan of the second and final tranche of its total 2012 contribution of US$343 million, the highest annual amount that Japan has ever made in 10 years of vigorous support for the Global Fund," a Global Fund press release reports.
Not only can bone marrow transplants be life-saving for children with acute lymphocytic leukemia, they may also cure peanut allergies. According to research presented during the American College of Allergy, Asthma and Immunology's Annual Scientific Meeting, a 10-year-old boy no longer had a peanut allergy after undergoing a bone marrow transplant.
Ark Biosciences, a biotech company developing proprietary therapeutics for viral infection and respiratory diseases, announced today the significant progress in its phase 2 proof-of-concept study of ziresovir in the treatment of hospitalized RSV infected infants.
Esaote, one of the world's leading manufacturers of medical diagnostic systems, is launching MyLab™Gamma, a best in class, highly-portable "green" ultrasound system at ESC Congress (European Society of Cardiology, Barcelona, 30th August - 3rd September). Based on Esaote's productivity-oriented operating platform, the super-light, feature packed portable system sets ultrasound free to be used in any environment - at a moment's notice.
› Verified 8 days ago